Karen Y. Capusan, DNP, CPNP-PC, explored RSV’s shifting epidemiology, seasonal trends, and new vaccines’ role in reducing hospitalizations at the 2025 NAPNAP National Conference. At the 2025 NAPNAP ...

Pediatricians face rising demands in specialty care and mental health, with programs such as REACH helping them manage these challenges. General pediatric providers and pediatric specialists across ...

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference. HPV is a sexually ...

Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, highlighted key updates on influenza, COVID-19, and RSV vaccines at the 2025 NAPNAP National Conference. At the 2025 NAPNAP National Conference on ...

Bobbie Monaco, MSN, CPNP-PC, provided a recap of her NAPNAP session regarding period poverty, and called for continued advocacy and awareness in the United States and globally. At the 2025 NAPNAP ...

Baricitinib shows promise for adolescent alopecia areata in phase 3 trial ...

At the 2025 NAPNAP Conference in Chicago, Jessica Spruit, DNP, CPNP-AC, FAANP, discussed the AAP's first clinical practice guideline on opioid prescribing. At the 2025 NAPNAP National Conference on ...

Mary Koslap-Petraco highlighted the need to address vaccine hesitancy, catch up on immunizations, and build trust with parents at the 2025 NAPNAP National Conference on Pediatric Health Care. At the ...

In the final part of this 5-part series, panelists discuss new allergy treatments such as Xolair, early immunotherapy, and their broader impact. Emerging research in food allergy and anaphylaxis is ...

Baricitinib shows promise for adolescent alopecia areata in phase 3 trial ...

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, comments on the ongoing measles outbreaks and encourages advocation for vaccines and accurate information. Measles cases have continued to ...